Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Novotech Logo Novotech Logo Novotech Logo Novotech Logo
  • Insights
  • Solutions
  • Expertise
  • Careers
  • About
  • Locations
  • Contact
  • English Language
  • search
  • English
  • Korean
  • Chinese, Simplified
  • Chinese, Traditional
  • Press Releases
  • Disease Reports
  • White Papers
  • Webinars
  • Podcasts
  • Events
  • Articles
  • Blogs
  • Case Studies
  • Frequently Asked Questions
  • Clinical Trials Glossary
  • Medical and Regulatory Consulting
  • Patient Recruitment and Site Selection
  • Early Phase Trials in Australia
  • Clinical Operations and Project Management
  • Site Management Organization (SMO)
  • Biometrics and Data Management
  • Virtual Clinical Trials
  • Real World Data
  • Laboratory Services
  • Flex
  • Oncology CRO services
  • Pharmacometric Services
  • Drug Development Consulting
  • GMO Solutions
  • Liver Disease CRO services
  • Infectious diseases and Vaccines CRO services
  • Orphan and rare disease CRO services
  • Clinical and Regulatory Strategy
  • Careers
  • Life at Novotech
  • Current Opportunities
  • Benefits and Recognition
  • Meet Our Teams
  • Growth and Development
  • Our Story
  • Our Impact
  • Our Approach
  • Awards and Recognitions
  • Our Leadership
  • Australia
  • Europe
  • Greater China
  • India
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • South Africa
  • South Korea
  • Thailand
  • United States
Novotech Mark
  • Insights
  • Solutions
  • Expertise
  • Careers
  • About
  • Locations
  • Contact
  • English Language
  • search
  • English
  • Korean
  • Chinese, Simplified
  • Chinese, Traditional
  • Press Releases
  • Disease Reports
  • White Papers
  • Webinars
  • Podcasts
  • Events
  • Articles
  • Blogs
  • Case Studies
  • Frequently Asked Questions
  • Clinical Trials Glossary
  • Medical and Regulatory Consulting
  • Patient Recruitment and Site Selection
  • Early Phase Trials in Australia
  • Clinical Operations and Project Management
  • Site Management Organization (SMO)
  • Biometrics and Data Management
  • Virtual Clinical Trials
  • Real World Data
  • Laboratory Services
  • Flex
  • Oncology CRO services
  • Pharmacometric Services
  • Drug Development Consulting
  • GMO Solutions
  • Liver Disease CRO services
  • Infectious diseases and Vaccines CRO services
  • Orphan and rare disease CRO services
  • Clinical and Regulatory Strategy
  • Careers
  • Life at Novotech
  • Current Opportunities
  • Benefits and Recognition
  • Meet Our Teams
  • Growth and Development
  • Our Story
  • Our Impact
  • Our Approach
  • Awards and Recognitions
  • Our Leadership
  • Australia
  • Europe
  • Greater China
  • India
  • Malaysia
  • New Zealand
  • Philippines
  • Singapore
  • South Africa
  • South Korea
  • Thailand
  • United States
Novotech Logo
English Language
English Language
  • English
  • Korean
  • Chinese, Simplified
  • Chinese, Traditional
Novotech Logo Novotech Logo PPC Novotech Logo
  • search
  • Insights
  • Solutions
  • Expertise
  • Careers
  • About
  • Locations
  • Contact
  • BACK
  • Latest Press Releases
  • Latest Disease Reports
  • Latest White Papers
  • Latest Webinars
  • Latest Podcasts
  • Upcoming Events
  • Latest Articles
  • Latest Blogs
  • Latest Case Studies
  • Latest Frequently Asked Questions
  • Clinical Trials Glossary
  • Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution
  • Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma
  • Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit
  • View All Press Releases
  • Obesity: Global Clinical Trial Landscape (2025)
  • Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)
  • Hepatitis B: Global Clinical Trial Landscape (2025)
  • View All Disease Reports
  • Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions
  • Obesity, from the bench to the bedside: Science, Solutions, and Stories
  • Mitigating Risk with Ex-US Clinical Trials
  • View All Webinars
  • Biotech moves fast. Your CRO should too.
  • Biotech moves fast. Your CRO should too.
  • JPM 2026
  • View All Events
  • Accelerating Obesity Drug Development in Australia and New Zealand with Novotech
  • Indian Biotech Phase IIB
  • Examining a Phase 1 COVID 19 Clinical Trial
  • View All Case Studies
  • How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies?
  • How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?
  • What makes in-vivo CAR therapies the next frontier in cell therapy?
  • View All Frequently Asked Questions
  • The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology
  • Therapeutic Radiopharmaceuticals: Download 2025 Global Report
  • 2025 Global Report for In-Vivo CAR Cell Therapy
  • View All White Papers
  • In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”
  • Inside China’s Early-Phase Trial Boom: Novotech’s China Managing Director Andy Liu Weighs In
  • Investor focus shifts to late-stage development in biotech, expert says
  • View All Article
  • ASH 2025: Signals for 2026 Hematology Planning
  • Europe At A Crossroads: Biotech Investment, Regulation And Partnership In Real Life
  • ESMO Congress 2025: Highlights from Berlin
  • View All Blogs
  • Charting the Next Chapter in Obesity Therapeutics
  • Beyond The Checkpoint: Next-Gen Strategies in Immuno-Oncology
  • Innovating Autoimmune Treatment with In Vivo CAR-T
  • View All Podcasts
  • BACK
  • Medical and Regulatory Consulting
  • Patient Recruitment and Site Selection
  • Early Phase Trials in Australia
  • Clinical Operations and Project Management
  • Site Management Organization (SMO)
  • Biometrics CRO and Data Management
  • Real world data
  • Laboratory Services
  • FLEX
  • BACK
  • Oncology CRO services
  • Pharmacometric Services
  • Drug Development Consulting
  • GMO Solutions
  • Liver Disease CRO services
  • Infectious diseases and Vaccines CRO services
  • Orphan and rare disease CRO services
  • Clinical and Regulatory Strategy
  • BACK
  • Careers
    Life at Novotech
    Current Opportunities
    Benefits and Recognition
    Meet Our Teams
    Growth and Development
  • BACK
  • Our Story
  • Our Impact
  • Our Approach
  • Awards and Recognitions
  • Our Leadership
Novotech Logo Novotech Logo Novotech Logo
Close the menu
December 16, 2025 News

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution

Sydney, Australia, December 2025, Novotech, a leading global full-service clinic...

Read more Notification Icon
August 29, 2025 News

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue…

SYDNEY, Australia – August 28, 2025, Novotech, a globally recognized full-servic...

Read more Notification Icon
July 31, 2025 News

Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to an...

Read more Notification Icon
View all news
April 19, 2025 Report

Obesity: Global Clinical Trial Landscape (2025)

Explore the evolving treatment landscape for obesity through Novotech CRO’s latest disease report....

Download
April 10, 2025 Report

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis....

Download
View all reports
November 18, 2025 Webinar

Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions

This webinar will explore the evolving landscape of B cell–targeting therapies in autoimmune diseases. Expert panelists will…

Watch
October 30, 2025 Webinar

Obesity, from the bench to the bedside: Science, Solutions, and Stories

This webinar will explore the biological, clinical, and societal impact of obesity while highlighting opportunities to advance…

Watch
View all webinars
September 5, 2025 Case Study

Accelerating Obesity Drug Development in Australia and New Zealand with Novotech

Addressing a Global Health PriorityObesity is one of the fastest-growing global health challenges, affecting more than 1 billion...

Read More
View all case studies
December 4, 2025 FAQ

How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies?

Gain insight into the emerging platforms, regulatory shifts, and clinical advances that are redefining early-phase oncology....

Read More
View all faqs
December 4, 2025 Whitepaper

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Early-phase oncology trials mark the most critical and fast-evolving stage of cancer research...

Download
View all whitepapers

Covid-19 Notice important updates

Read More

Find content relevant to:

Liver Disease Oncology Hematology Cell and Gene Therapy Immunology Company News Disease Reports Webinars
December 10, 2025-March 27, 2026 Events

Biotech moves fast. Your CRO should too.

Read More
December 18, 2025-January 30, 2026 Events

Biotech moves fast. Your CRO should too.

Read More
View all events
Novotech Logo Novotech Logo Novotech Logo
Close the menu
go left
go right
  • Medical and Regulatory Consulting

    Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services....

    Learn more
  • Patient Recruitment and Site Selection

    Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for...

    Learn more
  • Early Phase Trials in Australia

    Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash...

    Learn more
  • Clinical Operations and Project Management

    Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic...

    Learn more
  • Site Management Organization (SMO)

    Discover the power of clinical excellence with Acrostar's SMO Division, a dedicated entity operating as part of Novotech....

    Learn more
  • Biometrics CRO and Data Management

    Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis, regulatory submission and reporting....

    Learn more
  • Real world data

    Accelerating patient recruitment and drug development with real world data (RWD)...

    Learn more
  • Laboratory Services

    Our bioanalytical services assist our customers in every stage of their molecule development....

    Learn more
  • FLEX

    Our Keys to Boost Your SuccessCost: Predictable budget plan for your ongoing clinical pipeline.Flexibility: Quickly scale-up/-down to meet changing needs...

    Learn more
Novotech Logo Novotech Logo Novotech Logo
Close the menu
go left
go right
  • Expertise Icon

    Oncology CRO services

    The global Oncology landscape for Biotechnology companies...

    Learn more
  • Expertise Icon

    Pharmacometric Services

    Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending...

    Learn more
  • Expertise Icon

    Drug Development Consulting

    Novotech Drug Development Consulting is a full-service global product development and strategic regulatory group, providing comprehensive “lab to launch” program...

    Learn more
  • Expertise Icon

    GMO Solutions

    GMO Solutions: Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia....

    Learn more
  • Expertise Icon

    Liver Disease CRO services

    The global Liver Disease landscape for Biotechnology companies...

    Learn more
  • Expertise Icon

    Infectious diseases and Vaccines CRO services

    The global Infectious diseases and Vaccines CRO services landscape for Biotechnology companies...

    Learn more
  • Expertise Icon

    Orphan and rare disease CRO services

    The global Orphan and rare disease CRO services landscape for Biotechnology companies...

    Learn more
  • Expertise Icon

    Clinical and Regulatory Strategy

    Clinical and Regulatory Strategy: Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of...

    Learn more
Novotech Logo Novotech Logo Novotech Logo
Close the menu
  Global Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

  China Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Novotech Logo Novotech Logo Novotech Logo
Close the menu

Search Novotech

Insights

Therapeutic innovation is accelerating and understanding what’s next is vital. Explore expert perspectives, research updates, and industry analysis.

Discover More

Latest Press Releases

December 16, 2025 News

Novotech Issues White Paper to Help Sponsors Strengthen Early-Phase Oncology Strategy and Execution

Sydney, Australia, December 2025, Novotech, a leading global full-service clinic...

Read more Notification Icon
October 31, 2025 News

Novotech Maps Global Growth in Radiopharmaceutical Trials

Sydney, Australia, October 2025 — Novotech, a leading global clinical research o...

Read more Notification Icon
August 29, 2025 News

Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue…

SYDNEY, Australia – August 28, 2025, Novotech, a globally recognized full-servic...

Read more Notification Icon
July 31, 2025 News

Novotech Awarded Veeva Hero Award at 2025 Veeva R&D and Quality Summit

Novotech, a globally recognized full-service clinical research organization (CRO), is proud to an...

Read more Notification Icon
View all Press Releases

Latest Disease Reports

April 19, 2025 Report

Obesity: Global Clinical Trial Landscape (2025)

Explore the evolving treatment landscape for obesity through Novotech CRO’s latest disease report....

Download
April 10, 2025 Report

Idiopathic Pulmonary Fibrosis: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Idiopathic Pulmonary Fibrosis through Novotech CRO's in-depth disease analysis....

Download
February 26, 2025 Report

Hepatitis B: Global Clinical Trial Landscape (2025)

Discover the latest advancements in Hepatitis B through Novotech CRO's in-depth disease analysis....

Download
January 7, 2025 Report

Triple-Negative Breast Cancer: Global Clinical Trial Landscape (2024)

Discover the latest advancements in triple-negative breast cancer through Novotech CRO's in-depth disease analysis....

Download
View all Disease Reports

Latest White Papers

December 4, 2025 Whitepaper

The Starting Point of Breakthrough Therapies: A Deep Dive into Early-Phase Oncology

Early-phase oncology trials mark the most critical and fast-evolving stage of cancer research...

Download
October 15, 2025 Whitepaper

Therapeutic Radiopharmaceuticals: Download 2025 Global Report

Unlocking the Future of Precision Oncology with Therapeutic Radiopharmaceuticals....

Download
July 2, 2025 Whitepaper

2025 Global Report for In-Vivo CAR Cell Therapy

Explore global trends shaping in-vivo CAR therapies—delivery innovations, clinical trial momentum, and regulatory strategies across oncology and autoimmune diseases....

Download
June 12, 2025 Whitepaper

Live Biotherapeutic Products Whitepaper 2025

Live biotherapeutic products (LBPs) are gaining momentum in the drug development space, emphasisin...

Download
View all White Papers

Latest webinars

November 18, 2025 Webinar

Early Phase Excellence: Navigating B Cell Therapies in Autoimmune Conditions

This webinar will explore the evolving landscape of B cell–targeting therapies in autoimmune diseases. Expert panelists will…

Watch
October 30, 2025 Webinar

Obesity, from the bench to the bedside: Science, Solutions, and Stories

This webinar will explore the biological, clinical, and societal impact of obesity while highlighting opportunities to advance…

Watch
June 26, 2025 Webinar

Mitigating Risk with Ex-US Clinical Trials

This expert-led webinar explores how ex-US clinical trials can help biotech and mid-size pharma companies accelerate development…

Watch
May 27, 2025 Webinar

Navigating the Early Oncology Landscape: Market Trends and Insights

This presentation explores the evolving landscape of early-phase oncology clinical trials, offering key market trends and…

Watch
View all webinars

Latest Podcasts

December 4, 2025 Podcast

Charting the Next Chapter in Obesity Therapeutics

Episode description:More than 1.13 billion adults are living with obesity worldwide. In this episode, experts explain what’s driving the rise,...

November 27, 2025 Podcast

Beyond The Checkpoint: Next-Gen Strategies in Immuno-Oncology

Episode DescriptionJoin Sarah Anderson, Therapeutic Strategy Director - Oncology at Novotech, as she breaks down how the next generation of...

October 29, 2025 Podcast

Innovating Autoimmune Treatment with In Vivo CAR-T

Episode Description What will it take for in vivo CAR-T to move from oncology success to autoimmune breakthrough? Our latest episode...

September 10, 2025 Podcast

Navigating Regulatory Change & Market Shifts: CRO Perspectives

Episode description:In 2025, geopolitical tensions, regulatory shifts, and new FDA directions reshaped the clinical development landscape. In this four-part podcast...

View all Podcasts

Latest events

December 10, 2025-March 27, 2026 Events

Biotech moves fast. Your CRO should too.

Read More
December 18, 2025-January 30, 2026 Events

Biotech moves fast. Your CRO should too.

Read More
January 12-14, 2026 Events

JPM 2026

San Francisco, California

Read More
December 5-7, 2025 Events

ESMO Asia Congress 2025

Singapore

Read More
View all events

Latest articles

December 18, 2025 Article

In-Vivo CAR-T From Concept to Clinic – What It Will Take to Win the “Age of In-Vivo”

In-vivo CAR-T therapy delivers genetic instructions to immune cells inside the patient, aiming to reduce ex-vivo manufacturing constraints, shorten time...

Read more
December 2, 2025 Article

Inside China’s Early-Phase Trial Boom: Novotech’s China Managing Director Andy Liu Weighs In

In a recent PharmaBoardroom interview, Andy Liu, Novotech’s Managing Director for China, explains how regulatory reforms since 2015 and fa...

Read more
November 13, 2025 Article

Investor focus shifts to late-stage development in biotech, expert says

Investor sentiment in the biotech sector is shifting toward late-stage development, as funding increasingly favors companies with proven clinical d...

Read more
November 12, 2025 Article

The Evolving RNA Landscape: Strategy, Scale, and Speed

RNA therapeutics are moving fast....

Read more
View all articles

Latest blogs

December 16, 2025 Blog

ASH 2025: Signals for 2026 Hematology Planning

By: Sarah Anderson, Director Therapeutic Strategy & Pedro Rodriguez-Noriega, Associate Therapeutic Strategy Manag...

Read more
December 4, 2025 Blog

Europe At A Crossroads: Biotech Investment, Regulation And Partnership In Real Life

Earlier this month, our team joined a select group of investors, biotech leaders and policy experts to talk about the...

Read more
November 20, 2025 Blog

ESMO Congress 2025: Highlights from Berlin

This year’s ESMO Congress attracted more than 37K participants across five days of data and debate. Precision oncology, immunotherapy, and...

Read more
November 7, 2025 Blog

Rethinking Clinical Outsourcing: The Rise of the Flexible FSP Model

Clinical development today operates under increasing pressure: faster timelines, globalized trials, and rising complexity in both data and regulatory environments....

Read more
View all blogs

Latest case studies

September 5, 2025 Case Study

Accelerating Obesity Drug Development in Australia and New Zealand with Novotech

Addressing a Global Health PriorityObesity is one of the fastest-growing global health challenges, affecting more than 1 billion...

Read More
November 15, 2024 Case Study

Indian Biotech Phase IIB

BackgroundA biotech company based in India embarked on a Phase IIb clinical trial t...

Read More
April 24, 2024 Case Study

Examining a Phase 1 COVID 19 Clinical Trial

Background:Phase I clinical studies are critical in the development of new therapies especially in the rapidly changing biotech...

Read More
April 12, 2024 Case Study

Muscular Dystrophy – Multi-National and Multi-Site Trials Case Study

Company Background:ReveraGen BioPharma Inc., a clinical-stage drug development company based in the US, specializing in rare dis...

Read More
View all case studies

Latest Frequently Asked Questions

December 4, 2025 FAQ

How Is Early-phase Oncology Shaping The Next Generation Of Cancer Therapies?

Gain insight into the emerging platforms, regulatory shifts, and clinical advances that are redefining early-phase oncology....

Read More
October 15, 2025 FAQ

How Are Therapeutic Radiopharmaceuticals Advancing Precision Oncology?

Uncover the science, clinical applications, and global momentum behind this rapidly growing treatment modality....

Read More
July 2, 2025 FAQ

What makes in-vivo CAR therapies the next frontier in cell therapy?

Explore key questions and answers to learn how this innovative approach is transforming treatment possibilities.&nb...

Read More
June 12, 2025 FAQ

FAQs on Live Biotherapeutic Products

Live biotherapeutic products contain a single species or consortium of live microorganisms such as bacteria or yeast isolated from human...

Read More
View all Frequently Asked Questions

Talk to an expert team member

Receive a timely response to an enquiry about a service, process or technical questions.
Enter your details and the right person at Novotech will get in touch with you soon.

  • Insights
  • Solutions
  • Expertise
  • Careers
  • About
  • Contact
Novotech CRO Logo
© Novotech 2025 - All rights reserved. Privacy Whistle-blower policy Code of Conduct Vendors COC Disclaimer Modern Slavery Statement NHH Recruitment Scams - Website Alert Change of Banking Details Scam
Follow Novotech on Linked In Follow Novotech on Facebook Follow Novotech on Vimeo Follow Novotech on Spotify Follow Novotech on kakao Follow Novotech on Wechat
WeChat QR Code Close Icon